Part, Chapter, Paragraph
1 II, 5. 2. 6| randomised trials of statins. Lancet 366: 1267-1278.~Lewington
2 II, 5. 2. 6| 61 prospective studies. Lancet 360: 1903-1913.~Kannel WB (
3 II, 5. 2. 6| 55,000 vascular deaths. Lancet 370: 1829-1839.~Robinson
4 II, 5. 2. 6| overviews of randomised trials. Lancet 362: 1527-1535.~Vasan RS,
5 II, 5. 2. 7| MONICA Project populations. Lancet 335:675-87.~Palmieri L,
6 II, 5. 2. 7| cardiovascular disease. Lancet 353:1547-57.~Tunstall-Pedoe
7 II, 5. 2. 7| MONICA Project populations. Lancet 355:688-700~Uemura K, Pisa
8 II, 5. 2. 7| study): case-control study. Lancet 364: 937-952.~ ~ ~
9 II, 5. 3. 9| of the EUROCARE-4 study. Lancet Oncology 8 (9):773-783.~ ~
10 II, 5. 3. 9| analysis of EUROCARE-4 data. Lancet Oncology 8 (9): 784-796.~ ~
11 II, 5. 4. 3| in the Nordic countries (Lancet, 2000). These data allowed
12 II, 5. 4. 8| childhood diabetes in Europe. Lancet 11;355 873-6~EUDIP group (
13 II, 5. 5. 2| Delphi consensus study. The Lancet, Vol. 366, December 17/24/
14 II, 5. 5. 3| randomised clinical trial. The Lancet 371: 1085-1097.~Klosterkötter
15 II, 5. 5. 3| health without mental health. Lancet 370(9590):859-77.~Punnoose
16 II, 5. 5. 3| Stigma and mental health. Lancet 370(9590):810-11.~Sato M (
17 II, 5. 5. 3| classification: a prospective study. Lancet Neurol 4:627-634.~Osservatorio
18 II, 5. 5. 3| wake-up call for management. Lancet 359:1790-1791.~Rutter M,
19 II, 5. 5. 3| and multiple sclerosis. Lancet 7;268-277.~Ekestern E, Lebhart
20 II, 5. 6. 6| of chronic low-back pain. Lancet 354:581-585~Andersson HI,
21 II, 5. 6. 6| an observational study. Lancet 353:878-882~Combe B, Landewe
22 II, 5. 7. 7| in chronic renal failure. Lancet 2000 Jul 8;356(9224):147-
23 II, 5. 8. 7| population-base prevalence study. Lancet; 370: 741-750.~ ~Calverley
24 II, 5. 8. 7| inflammatory syndrome?. Lancet 2007; 370: 797-799.~ ~Fabbri
25 II, 5. 8. 7| population health data. Lancet 2006; 367: 1747-1757.~ ~
26 II, 5. 8. 7| prevalence, and future trends. Lancet 370: 765-773.~ ~Masa JF,
27 II, 5. 8. 7| Burden of Disease Study. Lancet 349: 1498–1504.~ ~Murtagh
28 II, 5. 12. 7| in Britain, 1950 to 2002. Lancet 367:645.~ ~National Cancer
29 II, 5. 12. 7| 2008): Liver Cirrhosis. Lancet 371: 838–51~ ~Shapiro CN,
30 II, 5. 12. 7| hepatitis C virus infection. Lancet Infect Dis 5:558-567.~ ~
31 II, 5. 14. 8| NB (2007): Dental caries. Lancet 2007; 369: 51–59.~Wid A (
32 II, 9. 1. 1| centres: a database study. Lancet 2007;369(9555):43-50.~Prysak
33 II, 9. 1. 2| Food with Folic Acid?", The Lancet, Vol 369, pp 641-642.~Bianchi
34 II, 9. 1. 2| Research Council Vitamin Study. Lancet 338: 131-7.~Schaefer C,
35 II, 9. 3. 1| Million Women Study. The Lancet; 362; 9382; 419-427.~ ~Boyle,
36 II, 9. 3. 1| of EUROCARE-4 data." The Lancet Oncology 8(9): 784-796.~ ~
37 II, 9. 3. 2| centres: a database study. Lancet 2007;369(9555):43-50.~ ~
38 II, 9. 3. 3| and HIV risk behaviours. Lancet 358:1835-42.~Kangas I, Andersen
39 II, 9. 3. 3| pregnancy, hormones, and HIV. Lancet 366:1141-42.~Nikula M, Kaponen
40 II, 9. 3. 3| heterosexual experience. Lancet 358(9296): 1843-1850.~Wellings
41 II, 9. 3. 3| context: a global perspective. Lancet Series: Sexual and Reproductive
42 II, 9. 3. 3| teenage pregnancy strategy: Lancet 368:1846-1848~ ~ ~
43 II, 9. 5. 6| the Million Women Study. Lancet 362 419–427.~ ~Bonté J (
44 III, 10. 1. 3| regional burden of disease. Lancet 2002; 360: 1347-60.~Fagard
45 III, 10. 2. 1| retrospective cohort study. Lancet, 2007; 369: 2015-20Martinet
46 III, 10. 2. 1| disease burden in adults. Lancet, 2006; 367: 749-53.~ ~WHO (
47 III, 10. 2. 1| crisis, common sense cure. Lancet 360:473-482.~ ~European
48 III, 10. 2. 4| the InterLymph Consortium. Lancet Oncol, 7(1):27-38.~ ~Schulte
49 III, 10. 3. 2| of industrial chemicals. Lancet 368, 2167-2178.~ ~Westfälisches
50 III, 10. 5. 1| intervention study. In: The Lancet. 2002 Oct 19;360(9341):1184-
51 III, 10. 5. 1| and the built environment. Lancet 29;370(9593): 1175-87~ ~
52 III, 10. 5. 3| increasing unemployment. Lancet, 208-213.~ ~Schumpeter J (
53 IV, 11. 6. 5| reflections on WHO's methods." The Lancet 361: 1817-20.~ ~Navarro
54 IV, 11. 6. 5| World Health Report 2000." Lancet 356: 1598-1601.~ ~Naylor
55 IV, 11. 6. 5| late-modern medicalisation.” Lancet 369: 698-700~ ~Vagac L,
56 IV, 13. 9 | regional burden of disease. Lancet 2002; 360: 1347-60.~Fazi
